NCT00001498View on ClinicalTrials.gov

A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

February 29, 1996

Study Completion Date

December 31, 2000

Conditions
Breast CancerBreast Neoplasms
Interventions
DRUG

methotrexate

DRUG

leucovorin

DRUG

5-fluorouracil

DRUG

cyclophosphamide

PROCEDURE

peripheral blood progenitor cell

DRUG

paclitaxel

DRUG

doxorubicin

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH